Travelzoo Inc.: Company Profile and SWOT Analysis

World Market Intelligence
February 11, 2012
27 Pages - SKU: WLMI6805836
Targacept Partnering 2009-2014
11/1/2014 | published by: Current Partnering
Targacept Partnering 2009-2014 The Partnering Agreements with Targacept 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. This report provides all the information you require  |  read more...
USD 995
Thoratec Corporation (THOR: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/6/2014 | published by: Plunkett Research, Ltd.
Thoratec Corporation (THOR: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Thoratec Corporation, THOR: NAS) compared to its top competitors  |  read more...
USD 1,795
Tabacuba
11/8/2014 | published by: ERC Group
Global, Regional & National Tobacco Players, 2014: Tabacuba Summary “Company Insight: Tabacuba” is a new report by ERC that is the result of ERC's extensive market research covering Tabacuba's profile in the tobacco products market. It provides  |  read more...
USD 975
TetraLogic Pharmaceuticals - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
TetraLogic Pharmaceuticals - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘TetraLogic Pharmaceuticals - Product Pipeline Review - 2014’, provides an overview of the TetraLogic Pharmaceuticals’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Tetraphase Pharmaceuticals Inc. - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
Tetraphase Pharmaceuticals Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Tetraphase Pharmaceuticals Inc. - Product Pipeline Review - 2014’, provides an overview of the Tetraphase Pharmaceuticals Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
TauRx Therapeutics Ltd. - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
TauRx Therapeutics Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘TauRx Therapeutics Ltd - Product Pipeline Review - 2014’, provides an overview of the TauRx Therapeutics Ltd’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Twitter Inc (TWTR: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/18/2014 | published by: Plunkett Research, Ltd.
Twitter Inc (TWTR: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Twitter Inc, TWTR: NYS) compared to its top competitors  |  read more...
USD 1,795
HomeAway Inc (AWAY: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/18/2014 | published by: Plunkett Research, Ltd.
HomeAway Inc (AWAY: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (HomeAway Inc, AWAY: NAS) compared to its top competitors  |  read more...
USD 1,795
Travelzoo Inc (TZOO: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/18/2014 | published by: Plunkett Research, Ltd.
Travelzoo Inc (TZOO: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Travelzoo Inc, TZOO: NAS) compared to its top competitors  |  read more...
USD 1,795
Takeda Partnering 2009-2014
11/1/2014 | published by: Current Partnering
Takeda Partnering 2009-2014 The Partnering Agreements with Takeda report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better  |  read more...
USD 995
 

SELECT A LICENSE

    Online Download  USD 120  
    Global Site License  USD 360  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!